Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Shock”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Not applicableStudy completedNCT04925518
What this trial is testing

Closed Loop Mechanical Ventilation and ECMO

Who this might be right for
Acute Respiratory Distress SyndromeCardiogenic Shock
University of Zurich 62
Not applicableUnknownNCT05339854
What this trial is testing

Evaluation of eCPR Survivors

Who this might be right for
Cardiac ArrestCardiopulmonary ResuscitationExtracorporeal Membrane Oxygenation Complication+2 more
Charite University, Berlin, Germany 30
Not applicableNot Yet RecruitingNCT07713511
What this trial is testing

INfections in Patients Treated With CAR-T

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple MyelomaB-Cell Non-Hodgkin Lymphoma+2 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 290
Large-scale testing (Phase 3)Looking for participantsNCT03401398
What this trial is testing

Stress Hydrocortisone In Pediatric Septic Shock

Who this might be right for
Septic Shock
Jerry Zimmerman 500
Not applicableStudy completedNCT03327493
What this trial is testing

Impact of Adrenoreceptor Expressions on Inflammatory Pattern in Refractory Cardiogenic Shock Under VA ECMO

Who this might be right for
Shock, CardiogenicExtra-Corporeal-Life-Support ( ECLS)Autonomic Nervous System Diseases+1 more
Central Hospital, Nancy, France 48
Not applicableStudy completedNCT02044575
What this trial is testing

Clock Genes in Patients With Refractory Septic Shock (SeptiClock) - Pilot Study

Who this might be right for
Septic Shock
Claudia Spies 20
Not applicableUnknownNCT04013269
What this trial is testing

Adjuvant Therapy With CytoSorb in Refractory Septic Shock

Who this might be right for
Septic Shock
Universitätsklinikum Hamburg-Eppendorf 32
Large-scale testing (Phase 3)Study completedNCT00514371
What this trial is testing

Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 22
Testing effectiveness (Phase 2)Looking for participantsNCT07657312
What this trial is testing

Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma

Who this might be right for
Cytokine Release SyndromeRecurrent Multiple MyelomaRefractory Multiple Myeloma
Naresh Bumma 35
Not applicableStudy completedNCT05101031
What this trial is testing

Evaluation of Fluid Volume in Patients With Refractory Hypotension (Fresh-ER)

Who this might be right for
Undifferentated Shock
Ivor Douglas 50
Early research (Phase 1)WithdrawnNCT03347994
What this trial is testing

Minnelide in Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Justin Watts
Early research (Phase 1)Active Not RecruitingNCT03016377
What this trial is testing

Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL

Who this might be right for
Acute Lymphoblastic LeukemiaImmune System DiseasesImmunoproliferative Disorders
UNC Lineberger Comprehensive Cancer Center 15
Large-scale testing (Phase 3)Ended earlyNCT03953677
What this trial is testing

Evaluation of the Effect of Dexmedetomidine on Phenylephrine Response During Refractory Septic Shock

Who this might be right for
Septic ShockVasopressor Resistance
Centre Hospitalier Universitaire Dijon 32
Testing effectiveness (Phase 2)Looking for participantsNCT06421675
What this trial is testing

Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
Ontario Clinical Oncology Group (OCOG) 40
Not applicableStudy completedNCT05788211
What this trial is testing

REnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO)

Who this might be right for
Cardiogenic ShockRenal Replacement TherapyVenoarterial Extracorporeal Membrane Oxygenation
University Hospital, Bordeaux 93
Testing effectiveness (Phase 2)UnknownNCT05275647
What this trial is testing

Efficacy and Safety of Low Energy Shock Wave Plus BotulinumToxin A in Treating Patients With Interstitial Cystitis

Who this might be right for
Interstitial Cystitis
Buddhist Tzu Chi General Hospital 75
Not applicableStudy completedNCT04934566
What this trial is testing

Venous Oxygen Saturation During ECMO Support

Who this might be right for
Cardiogenic Shock
University Hospital, Lille 48
Testing effectiveness (Phase 2)Looking for participantsNCT06806033
What this trial is testing

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Who this might be right for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Hoffmann-La Roche 130
Testing effectiveness (Phase 2)WithdrawnNCT04316611
What this trial is testing

Potassium Chloride in Out-of-hospital Cardiac Arrest Due to Refractory Ventricular Fibrillation

Who this might be right for
Out-of-hospital Cardiac Arrest (OHCA)
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)Study completedNCT04150913
What this trial is testing

Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

Who this might be right for
Non Hodgkin LymphomaRefractory Non-Hodgkin LymphomaRelapsed Non Hodgkin Lymphoma+3 more
Marcela V. Maus, M.D.,Ph.D. 15
Next Page